Specific bacterial strains induce the production of interleukin-6 (IL-6), interleukin-10 (IL-10), and transforming growth factor-beta (TGF-β), promoting tumor growth and evading immune surveillance by inhibiting cytotoxic T cells and natural killer (NK) cells. The gene discussed is TGFB1; the disease is neoplasm.